Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Current Diabetes Reports|November 2, 2006
Pramlintide: A new tool in diabetes managementLaura L Want, Robert E RatnerCurrent Diabetes Reports|April 3, 2016
Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists Utilizing Data from the Exenatide Clinical Trial Development ProgramHui Peng, Laura L Want, Vanita R ArodaDiabetes Technology & Therapeutics|May 23, 2002
Adjunctive therapy with the amylin analogue pramlintide leads to a combined improvement in glycemic and weight control in insulin-treated subjects with type 2 diabetesRobert E Ratner, Laura L Want, Mark S Fineman, et al.Diabetes Care|December 28, 2002
Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumpsClaresa Levetan, Laura L Want, Christian Weyer, et al.Pageof 1